IRAK1 and breast cancer: We further evaluated the total protein levels of IRAK1 from the CPTAC dataset; the results revealed higher expressions in the primary tumor of LUAD, clear cell RCC, UCEC, and breast cancer than in normal tissues (Figure 1C).